|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||-3.59||2939.80||1786.50||46,375.93|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|Reliance Growth Fund - Retail Plan (G)||918,025|
|DSP BlackRock Top 100 Equity Fund - Regular Plan (G)||646,583|
|DSP BlackRock Equity Fund - Regular Plan (G)||377,619|
|DSP BlackRock Equity Fund - Regular Plan (D)||377,619|
Ranbaxy Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 15,684.06 crore.The company has reported a consolidated sales of Rs 2,858.96 crore and a Net Loss of Rs 158.49 crore for the quarter ended Dec 2013.
The company management includes Tsutomu Une - Chairman, Arun Sawhney - Managing Director & CEO, Akihiro Watanabe - Director, Anthony H Wild - Director, Kazunori Hirokawa - Additional Director, Rajesh V Shah - Director, Takashi Shoda - Director, Percy K Shroff - Director.
It is listed on the BSE with a BSE Code of 500359 and the NSE with an NSE Code of RANBAXY.
Its Registered office is at A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar Mohali,Punjab - 160071.
Their Registrars are Alankit Assignment Ltd.